| [1] |
国家卫生健康委员会办公厅, 国家中医药管理局办公室. 新型冠状病毒感染的肺炎诊疗方案(试行第六版)[R/OL]. [2020-02-24]http://www.nhc.gov.cn/xcs/zhengcwj/202002/8334a8326dd94d329df351d7da8aefc2.shtml
|
| [2] |
Chen L, Liu W, Zhang Q, et al. RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak[J]. Emerg Microbes Infect, 2020, 9(1):313-319.
doi: 10.1080/22221751.2020.1725399
URL
|
| [3] |
Chu DKW, Pan Y, Cheng SMS, et al. Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia[J]. Clin Chem,pii:hvaa029.
|
| [4] |
Li T, Qiu Z, Zhang L, et al. Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome[J]. J Infect Dis, 2004, 189(4):648-651.
doi: 10.1086/381535
URL
|
| [5] |
Yilla M, Harcourt BH, Hickman CJ, et al. SARS-corona-virus replication in human peripheral monocytes/macrophages[J]. Virus Res, 2005, 107(1):93-101.
doi: 10.1016/j.virusres.2004.09.004
URL
|
| [6] |
Zhang Z, Xu D, Li Y, et al. Longitudinal alteration of circulating dendritic cell subsets and its correlation with steroid treatment in patients with severe acute respiratory syndrome[J]. Clin Immunol, 2005, 116(3):225-235.
doi: 10.1016/j.clim.2005.04.015
URL
|
| [7] |
Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome[J]. Lancet Respir Med,2020,pii: S2213-2600(20)30076-X.
|
| [8] |
Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China[J/OL]. Allergy, 2020-02-19[2020-02-24]https://www.ncbi.nlm.nih.gov/pubmed/32077115.
|
| [9] |
李太生, 邱志峰, 韩扬, 等. 严重急性呼吸综合征急性期T淋巴细胞亚群异常改变[J]. 中华检验医学杂志, 2003, 26(5):297-299.
|
| [10] |
谢静, 范洪伟, 李太生, 等. 长期随访的严重急性呼吸综合征患者T淋巴细胞亚群动态变化[J]. 中国医学科学院报, 2006, 28(2):253-255.
|
| [11] |
Shimabukuro-Vornhagen A, Gödel P, Subklewe M, Stemmler HJ, et al. Cytokine release syndrome[J]. J Immunother Cancer, 2018, 6(1):56.
doi: 10.1186/s40425-018-0343-9
pmid: 29907163
|
| [12] |
Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, et al. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza[J]. Crit Care, 2009, 13(6):R201.
doi: 10.1186/cc8208
URL
|
| [13] |
Kindler E, Thiel V, Weber F. Interaction of SARS and MERS Coronaviruses with the Antiviral Interferon Response[J]. Adv Virus Res, 2016, 96:219-243.
doi: S0065-3527(16)30045-8
pmid: 27712625
|
| [14] |
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet,2020, 395(10223):497-506.
doi: 10.1016/S0140-6736(20)30183-5
URL
|
| [15] |
Zhou YG, Fu BQ, Zheng XH, et al. Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus[J/OL]. BioRxiv preprint, 2020-02-20[2020-02-24]https://www.biorxiv.org/content/10.1101/2020.02.12.945576v1.
|
| [16] |
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel corona-virus pneumonia in Wuhan, China: a descriptive study[J]. Lancet, 2020, 395(10223):507-513.
doi: 10.1016/S0140-6736(20)30211-7
URL
|
